עקוב אחר
Paul Peter Tak
Paul Peter Tak
Candel Therapeutics, GlaxoSmithKline, Kintai Therapeutics, Academic Medical Center, Amsterdam
כתובת אימייל מאומתת בדומיין candeltx.com - דף הבית
כותרת
צוטט על ידי
צוטט על ידי
שנה
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
D Aletaha, T Neogi, AJ Silman, J Funovits, DT Felson, CO Bingham III, ...
Arthritis & rheumatism 62 (9), 2569-2581, 2010
154582010
NF-κB: a key role in inflammatory diseases
PP Tak, GS Firestein
The Journal of clinical investigation 107 (1), 7-11, 2001
50092001
Genetics of rheumatoid arthritis contributes to biology and drug discovery
Y Okada, D Wu, G Trynka, T Raj, C Terao, K Ikari, Y Kochi, K Ohmura, ...
Nature 506 (7488), 376-381, 2014
25872014
Tumor necrosis factor antagonist mechanisms of action: a comprehensive review
D Tracey, L Klareskog, EH Sasso, JG Salfeld, PP Tak
Pharmacology & therapeutics 117 (2), 244-279, 2008
21822008
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
EA Stahl, S Raychaudhuri, EF Remmers, G Xie, S Eyre, BP Thomson, Y Li, ...
Nature genetics 42 (6), 508-514, 2010
16022010
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis
W Hueber, DD Patel, T Dryja, AM Wright, I Koroleva, G Bruin, C Antoni, ...
Science translational medicine 2 (52), 52ra72-52ra72, 2010
11012010
Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis
FA Koopman, SS Chavan, S Miljko, S Grazio, S Sokolovic, PR Schuurman, ...
Proceedings of the National Academy of Sciences 113 (29), 8284-8289, 2016
9702016
2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of …
A Ravelli, F Minoia, S Davì, AC Horne, F Bovis, A Pistorio, M Aricò, ...
Arthritis & rheumatology 68 (3), 566-576, 2016
9382016
MicroRNA‐146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins
Y Tang, X Luo, H Cui, X Ni, M Yuan, Y Guo, X Huang, H Zhou, N de Vries, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
9212009
Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity
PP Tak, TJM Smeets, MR Daha, PM Kluin, KAE Meijers, R Brand, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1997
7371997
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
GM Bartelds, CA Wijbrandts, MT Nurmohamed, S Stapel, WF Lems, ...
Annals of the rheumatic diseases 66 (7), 921-926, 2007
7342007
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis
JC Robson, PC Grayson, C Ponte, R Suppiah, A Craven, A Judge, ...
Arthritis & Rheumatology 74 (3), 393-399, 2022
641*2022
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
J Braun, T Pham, J Sieper, J Davis, SJ Van der Linden, M Dougados, ...
Annals of the rheumatic diseases 62 (9), 817-824, 2003
6302003
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
GJ Wolbink, M Vis, W Lems, AE Voskuyl, E De Groot, MT Nurmohamed, ...
Arthritis & Rheumatism 54 (3), 711-715, 2006
6192006
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
S Raychaudhuri, EF Remmers, AT Lee, R Hackett, C Guiducci, NP Burtt, ...
Nature genetics 40 (10), 1216-1223, 2008
6142008
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
L Gossec, JS Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, ...
Annals of the rheumatic diseases 71 (1), 4-12, 2012
6122012
The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis
PP Tak, B Bresnihan
Arthritis & Rheumatism 43 (12), 2619-2633, 2000
5632000
Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis
JJ Haringman, DM Gerlag, AH Zwinderman, TJM Smeets, MC Kraan, ...
Annals of the rheumatic diseases 64 (6), 834-838, 2005
5392005
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
DM Gerlag, K Raza, LGM Van Baarsen, E Brouwer, CD Buckley, ...
Annals of the rheumatic diseases 71 (5), 638-641, 2012
5362012
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
MH Buch, JS Smolen, N Betteridge, FC Breedveld, G Burmester, T Dörner, ...
Annals of the rheumatic diseases 70 (6), 909-920, 2011
5312011
המערכת אינה יכולה לבצע את הפעולה כעת. נסה שוב מאוחר יותר.
מאמרים 1–20